Age-related macular degeneration

Macular Degeneration is amongst the main eye conditions which lead to loss of vision.

Macular Degeneration is amongst the main eye conditions which lead to loss of vision.


iliaki ekfilisi tis oxras kilidasIt is the most common cause of blindness in patients over the age of 65 in the developed world. Macular degeneration is hereditary, but age factors, smoking and gender (women are more prone) also play a vital role in its appearance. Visual loss is usually rapid, and the damage caused by advanced degeneration is irreversible.

Symptoms are mainly blurred vision, difficulty in reading and recognizing people, reduced color perception, and "dark spots" in the central vision.

Early diagnosis and treatment may slow the progression of the disease to help stabilize the condition as well as reduce the percentage of vision loss. In many cases it can improve vision.


Intravitreal injections are drugs that are administered to the eye cavity to achieve immediate and targeted action against serious intraocular diseases that are threatening to vision.

Such diseases are related to the wet form of macular degeneration, diabetic edema, central retinal vein thrombosis, and generally all types of inflammation of the eye.

It is actually a micro-intervention in which the drug is injected into the inside of the eye, using a small needle, wherever it is needed depending on the individuals condition. Even though injections are used on the eye, the process is not as painful as it sounds and some have said it is rather painless. 

With the treatment of intravitreal injections, many people have been helped to improve the quality of their vision. It is the latest technological development in the treatment of macular degeneration and diabetic retinopathy.